We are thrilled to announce that Keizo Takemi, the Minister of Health, Labour and Welfare, visited KORTUC INC. at the Japan Innovation Campus in Palo Alto. This visit provided a valuable opportunity to showcase our innovative technologies and discuss our role in the future of oncology.
KORTUC INC. provides an innovative drug to safely maximize the effectiveness of radiotherapy. By injecting Hydrogen Peroxide directly into the tumor just before radiotherapy, we can make tumors sensitive to radiotherapy and solve the longtime and fundamental limitation of radiotherapy. We are now conducting registrational Phase2 clinical trials in both the UK and India and are on track to launch our product in UK/EU/US and India in 2028.
We are deeply grateful for the Minister’s visit and the positive dialogue that took place. His encouragement reinforces our commitment to creating a paradigm shift in cancer treatment and improving patient outcomes.
